According to Portage Biotech's latest financial reports the company's total assets are $49.03 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $99.12 M | -49.08% |
2022-03-31 | $0.19 B | 11.32% |
2021-03-31 | $0.17 B | 0.97% |
2020-03-31 | $0.17 B | -0.31% |
2019-03-31 | $0.17 B | 1636.63% |
2018-03-31 | $10 M | -83.3% |
2017-03-31 | $59.9 M | 374.34% |
2016-03-31 | $12.62 M | 166.66% |
2015-03-31 | $4.73 M | -10.02% |
2014-03-31 | $5.26 M | 53.41% |
2013-03-31 | $3.43 M | -54.34% |
2012-03-31 | $7.51 M | -21.91% |
2011-03-31 | $9.62 M | -7.28% |
2010-03-31 | $10.37 M | 722.59% |
2009-03-31 | $1.26 M | -75.22% |
2008-03-31 | $5.08 M | -12.01% |
2007-03-31 | $5.78 M | 23.72% |
2006-03-31 | $4.67 M | 11.45% |
2005-03-31 | $4.19 M | 78.28% |
2004-03-31 | $2.35 M | 11944.93% |
2003-03-31 | $0.01 M | -84.92% |
2002-03-31 | $0.12 M | -77.53% |
2001-03-31 | $0.57 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.27 M | -99.45% | Bahamas |
NRC Health
NRC | $0.12 B | 146.58% | ๐บ๐ธ USA |